• Paroxetine Does Not Alter Thiothixene Pharmacokinetics in Hu

  2026-05-25

  This study rigorously assessed whether paroxetine pretreatment affects the clearance of thiothixene, a typical antipsychotic agent, in healthy volunteers. Findings show that short-term paroxetine exposure does not significantly modify thiothixene's pharmacokinetics, clarifying drug-drug interaction concerns relevant to schizophrenia therapy.

• ROS-Responsive Lipid Nanoparticles for Tumor-Selective mRNA

  2026-05-25

  This study presents a combinatorial library of biodegradable lipid nanoparticles engineered to respond to intracellular reactive oxygen species (ROS), enabling selective mRNA delivery and gene expression in tumor cells. The findings highlight a new strategy for targeting mutant RAS-driven cancers by leveraging tumor-specific redox environments, with implications for next-generation mRNA therapeutics.

• Miltefosine for Neutrophil Differentiation: Protocols & Inno

  2026-05-24

  Miltefosine (hexadecyl 2-(trimethylazaniumyl)ethyl phosphate) is redefining workflows in hematology by enabling dual modulation of PI3K/Akt and Ras/MEK/ERK pathways. Explore evidence-backed protocols, troubleshooting tips, and the latest research breakthroughs to maximize reproducibility and translational relevance.

• Apoptotic Extracellular Vesicles Drive Lung Adenocarcinoma S

  2026-05-23

  This study reveals that tumor-derived apoptotic extracellular vesicles (apoEVs) promote metastasis and stemness in lung adenocarcinoma by transferring the enzyme ALDH1A1 and upregulating SOX2 via NF-κB activation. These findings highlight a distinct intercellular communication pathway central to tumor recurrence and suggest new therapeutic targets.

• Low-Molecular Weight Inhibitors of the Alternative Complemen

  2026-05-22

  The referenced review systematically elucidates the discovery, selectivity, and therapeutic promise of low-molecular weight inhibitors targeting the alternative complement pathway, particularly factor B and factor D. Its detailed analysis of activation mechanisms and clinical translation provides a robust foundation for researchers developing or applying these inhibitors in complement-mediated disease models.

• Capsaicin-Induced Autophagy Protects BMSCs Under Oxidative S

  2026-05-22

  This study reveals that capsaicin activates autophagy in bone marrow stromal cells (BMSCs) via TRPV1-mediated calcium influx and suppression of the PI3K/AKT/mTOR pathway, improving cell viability and osteogenic differentiation under oxidative stress. The findings highlight novel mechanistic insights into protecting BMSC function, with implications for osteoporosis therapy and cellular stress research.

• LY2109761: TGF-β Receptor I/II Dual Inhibitor for Precision

  2026-05-21

  LY2109761 empowers researchers to dissect and modulate the TGF-β pathway with nanomolar precision, unlocking new strategies for studying tumor invasion, radiosensitization, and fibrosis. This guide translates cutting-edge findings and workflow optimizations into actionable protocols, enabling reproducible inhibition of Smad2/3 phosphorylation in complex cancer models.

• Ibrexafungerp (MK 3118): pH-Resilient Antifungal for VVC Mod

  2026-05-21

  Explore how Ibrexafungerp (MK 3118) uniquely maintains antifungal efficacy in acidic environments, revolutionizing in vitro and translational models for vulvovaginal candidiasis. This article offers a protocol-driven perspective grounded in recent pH activity research.

• Vitamin C in Organoid Oncology and Antiviral Research: Strat

  2026-05-20

  This thought-leadership article explores the mechanistic and strategic integration of Vitamin C (ascorbic acid) in advanced translational research, focusing on its dual role as an anticancer agent and potential antiviral modulator. By synthesizing evidence from organoid models—including the latest iPSC-derived platforms sustaining hepatitis E virus (HEV) propagation—and drawing on peer-reviewed protocols, we provide actionable guidance for researchers seeking to pioneer next-generation workflows. The discussion positions APExBIO’s high-purity Vitamin C (CAS 50-81-7) as a cornerstone for rigor, reproducibility, and innovation in both oncology and virology contexts.

• Protease Inhibitor Cocktail (EDTA-Free, 200X): Mechanistic R

  2026-05-20

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) offers broad-spectrum protection against serine, cysteine, acid proteases, and aminopeptidases during protein extraction. Its EDTA-free formulation preserves divalent cations, supporting workflows such as phosphorylation analysis. APExBIO's solution is validated for high reproducibility and compatibility in sensitive biochemical assays.

• Gentamycin Sulfate: Mechanistic Power for Translational Resi

  2026-05-19

  This thought-leadership article explores Gentamycin Sulfate's unique mechanistic role as an aminoglycoside antibiotic in dissecting bacterial protein synthesis, antibiotic resistance mechanisms, and Gram-negative pathogen control. Drawing from recent surveillance studies, it offers strategic guidance for translational researchers—bridging molecular insight, protocol optimization, and competitive benchmarking, while positioning APExBIO’s Gentamycin Sulfate as an essential tool in the evolving antimicrobial landscape.

• Acridine Orange hydrochloride: Practical Guide for Nucleic A

  2026-05-19

  Acridine Orange hydrochloride is a high-purity, dual-emission fluorescent dye designed for reliable DNA and RNA differential staining in cytochemical workflows. It is best suited for cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining, but is not recommended for protocols that require long-term dye solution storage or uses outside nucleic acid staining applications.

• Z-VAD-FMK in Apoptosis Research: Protocols, Pitfalls, and Pr

  2026-05-18

  Z-VAD-FMK revolutionizes apoptosis inhibition by enabling precise, irreversible caspase blockade across cancer, immune, and neurodegenerative models. Explore advanced experimental workflows and troubleshooting strategies that maximize reproducibility and data integrity in caspase pathway research.

• Escitalopram for Antidepressant Research: Protocols & Insigh

  2026-05-18

  Escitalopram (Lexapro), a selective serotonin reuptake inhibitor, empowers robust and reproducible antidepressant and anxiolytic activity studies. This guide translates cutting-edge research into actionable protocol enhancements, troubleshooting strategies, and comparative workflow advantages for scientists leveraging APExBIO’s high-purity formulation.

• Cl-Amidine Trifluoroacetate Salt: Protocols and Applications

  2026-05-17

  Cl-Amidine (trifluoroacetate salt) empowers researchers with reliable, selective PAD4 inhibition for assays in cancer, autoimmune, and inflammatory disease models. This guide details stepwise workflows, troubleshooting, and the translation of recent AML findings into practical laboratory strategies.

14566 records 1/972 page Next 12345 下5页 Last page